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The X-ray crystal structure of the complex of bovine @-trypsin with a synthetic inhibitor, 6-amidino-2-naphthyl+guanidinobenzoate (FUT), has 
been determined by the difTerence Fourier method at 2.06 A resolution and refined to a crystallographic R-factor of 0.191 using the restrained 
least-squares method of Hendrickson and Konnert. The structure of trypsin is almost identical to previously published structures. A hydroly~ 
fragment of the inhibitor, p-~nidino~nzoate, is covalently bound to the active site Serrgs-Oy, forming an ester bond. The inhibitor fragment 
occupies the specificity pocket with a hydrogen-bonding pattern similar to that of benzamidine-inhibited trypsin. 
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1. INTRODUCTION 
6-Amidino-2-naphthyl-4-guanidinobenzoate (FUT) 
is a potent trypsin inhibitor which has been used 
clinically to treat acute pancreatitis [l]. The guanidine 
group and the amidine group, located at opposite ends 
of the FUT molecule, might be responsible for the 
specific binding to trypsin. It has not been clear which 
of those two functional groups interacts with the 
specificity pocket of trypsin, with whieh the lysine or 
arginine side chain of a substrate has a specific interac- 
tion during the hydrolysis by trypsin. Furthermore, 
FUT has an ester bond which is slowly hydrolyzed by 
trypsin under physiological conditions (Noji, S., per- 
sonal communication). In order to understand the in- 
hibitory mechanism of FUT and the mechanism of its 
hydrolysis by trypsin, we have carried out a molecular 
dynamics study of the cmplex formed by trypsin and 
FUT [2]. At the same time, we have crystallized FUT- 
inhibited trypsin and performed an X-ray crystallo- 
graphic analysis in order to obtain a detailed structure 
of the complex for correlation with the results of the 
molecular dynamics study. The X-ray crystallographic 
results are presented here. 
trypsin were grown by the vapor diffusion technique using the 
hanging-drop method. Conditions for the crystallization were similar 
to those used in the case of benzamidine-inhibited trypsin [3]. 
Droplets of mother liquor containing 2.6 mM trypsin, 40 mM FUT, 
10 mM CaCl2, and 0.6 M ammonium sulfate were slowly equilibrated 
at 4°C against 1.5 M ammonium sulfate solution. Long prismatic 
crystals up to 0.2 mm x 0.4 mm x 1 .O mm were obtained after one 
month. 
X-ray diffraction experiments were done at the Photon Factory, 
National Laboratory of High Energy Physics (Tsukuba, Japan). The 
space group of the crystal was P21212i with cell constants a = 54.96 A, 
b = 58.50 A and c = 67.35 A, which are nearly identical to those of the 
o~horhombic rystal of benz~din~inhibited trypsin. Intensity data 
were collected using a four-circle diffractometer with a wiggler beam 
monochromated to 1.1 A wavelength. During the data collection, 
crystals were cooled to 5°C by blowing cool air over them. A total of 
16 675 reflections within 10-2.06 A resolution range were measured 
using three crystals. The intensity data of each crystal were corrected 
for absorption [4] and then all data were merged to yield 13 912 in- 
dependent reflections. Rmerse. defined as C(I- <I>)/.EI summed 
over all measurements, was 0.041. 
2. MATERIALS AND METHODS 
Bovine trypsin was purchased from Sigma (Type III). FUT was a 
gift from Eisai Pharmaceutical Company. Crystals of FUT-inhibited 
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A first difference Fourier map was calculated between the observed 
structure factor amplitudes and the structure factor calculated from 
the trypsin moiety of benzamidine-inhibited trypsin [3]. All Fourier 
calculations were doing using the PROTEIN program package [5]. 
Within a specificity pocket, there was a positive difference density 
which was interpreted as being due to the ~-guanidinobenzoate 
moiety of the inhibitor, based on its shape and size. At this stage, it 
was not clear from the density map whether the binding of the frag- 
ment was non-covalent or covalent. The crystallographic refinement 
was started from the benzamidine-inhibited trypsin structure omitting 
the bound inhibitor benzamidine. 12 936 reflection data from 6.0 A 
to 2.06 A resolution with intensity greater than 2u were used for the 
calculation. The calculation was done with the restrained least- 
squares program by Hendrickson and Konnert [a]. After 7 cycles of 
refinement, the inhibitor fragment p-guanidinobenzoate was fitted to 
the electron density map to form two possible models, a covalent 
model and a non-covalent model. After several further cycles on those 
two models and examinations of electron density maps, the covalently 
bonded model was selected as preferable. This final R-factor was 
19.1%. including 12 atoms of the inhibitor fragment, one calcium 
ion, and 77 water molecules. 
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3. RESULTS AND DISCUSSION 
Overall folding of FUT-inhibited trypsin is almost 
identical to the previously published orthorhombic 
crystal structure of benzamidine-inhibited trypsin [3]. 
When the FUT-inhibited trypsin is superposed on the 
benzamidine-inhibited trypsin at the peptide backbone 
atoms (Ccu, C, N, 0), the root-mean-square differences 
between the two structures are 0.13 A for backbone 
atoms and 0.23 A for all atoms. 
Fig. 1 shows the superposed structures of the inhibitor 
and adjacent residues of the FUT-inhibited trypsin and 
benzamidine-inhibited trypsin. In the FUT-inhibited 
trypsin, the hydrolyzed fragment of FUT, namely p- 
guanidinobenzoate, binds to the specificity pocket of 
trypsin, which is supposed to interact with the lysine or 
arginine side chain of a peptide substrate. The inhibitor 
fragment is covalently attached to trypsin through an 
ester bond between inhibitor carboxylate and 
Ser195-0y. The conformations in the region of the in- 
hibitor are almost identical in the two structures except 
for somewhat larger movements of side chain atoms 
that are in close contact or are hydrogen-bonded to in- 
hibitor atoms. Those movements are probably due to 
the larger size of p-guanidinobenzoate compared to 
benzamidine. 
The hydrogen-bonding scheme around p-guanidino- 
benzoate is shown in fig.2 with corresponding in- 
teratomic distances. The guanidine group is hydrogen- 
bonded to As~‘*~-OS~ and -062, Se?‘-Oy, and a main 
chain carbonyl oxygen of Cily219. A similar hydrogen- 
bonding scheme has been observed in benzamidine- 
inhibited trypsin, in which an amidine group par- 
ticipates in the hydrogen bonds instead of the guanidine 
group. But there is a difference in that the FUT- 
inhibited trypsin has bifurcated hydrogen bonds of 
Gly219 oxygen to two nitrogens of the guanidine group. 
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Fig.2. Hydrogen-bonding scheme and distances around the 
covalently bound inhibitor p-guanidinobenzoate in FUT-inhibited 
trypsin. Hydrogen bonds are shown as dashed lines with distances in 
A. 
In the commonly accepted hydrolysis mechanism of 
trypsin, main chain amide nitrogens of G~Y’~~ and 
Ser’95 form a so-called ‘oxyanion hole’ and stabilize 
negative charge on the substrate carbonyl oxygen dur- 
ing the nucleophilic attack on carbonyl carbon [7]. In 
FUT-inhibited trypsin, the distances from inhibitor car- 
bony1 oxygen to GIY’~~ N and Ser”’ N are 3.4 A and 
3.3 A, respectively, which are rather longer than typical 
hydrogen bonds. As compared to the side chains of 
lysine and arginine which are specific residues of 
trypsin-hydrolyzable substrates, p-guanidinobenzoate 
is rigid and has little conformational freedom. Further- 
more, p-guanidinobenzoate is ‘anchored’ to the 
specificity pocket on both sides with several strong 
hydrogen bonds and with one covalent bond to trypsin. 
The approach of carbonyl oxygen to the oxyanion hole 
seems to be hindered by those conformational and geo- 
metrical constraints. 
A kinetic study shows that hydrolysis of FUT by tryp- 
sin proceeds in two steps (Noji,S., personal com- 
munication). The first step is quite rapid and produces 
Fig.1. Stereo drawing of substrate binding site residues and bound inhibitors of FUT-inhibited trypsin (solid line) and benzamidine-inhibited 
trypsin (dashed line). Structures were superposed by a root-mean-square fit of trypsin backbone atoms. Small crosses are bound water molecules. 
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an acylated enzyme, which we have seen in this REFERENCES 
crystallographic study. The second step of the reaction, 
cleavage of the ester bond of the acylated enzyme, is 
very slow under physiologist conditions. FUT may be 
regarded as a ‘suicide inhibitor’ to some extent. Our 
result suggests that the slow rate of deacylation of the 
FUT-inhibited enzyme may be due to the less favorable 
interaction between the carbonyl oxygen of the acyl 
group and the oxyanion hole of trypsin. 
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